Guess which ASX defence stock could rocket 100%+

Let's see what analysts at Bell Potter are saying about this high-risk, high-reward option.

| More on:
Man flies flat above city skyline with rocket strapped to back

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Titomic Ltd, a cold spray technology company, is seen as a high-potential ASX defence stock, with Bell Potter highlighting its US$1.7 million contract for next-gen defence components as a key catalyst for future opportunities.
  • The company’s advanced Titomic Kinetic Fusion technology in additive manufacturing is gaining traction in critical defence segments like hypersonics and satellites, poised to leverage growing defence modernization initiatives.
  • Bell Potter maintains a speculative buy rating for Titomic with a bold price target of 50 cents, suggesting a potential 120% upside due to expanding defence budgets and anticipated new contracts and funding announcements.

If you have a high tolerance for risk and want some exposure to the booming defence sector, then it could be worth considering the ASX stock in this article.

That's because Bell Potter believes it could rise more than 100% from current levels over the next 12 months.

Which ASX defence stock?

The stock that Bell Potter is urging investors to buy is Titomic Ltd (ASX: TTT).

It is a $340 million cold spray technology company. It applies this technology in additive manufacturing and coating and repairs.

Bell Potter highlights that cold spray uses compressed gas to accelerate metal powders to supersonic speeds, enabling kinetic energy to fuse/plastically deform the particles onto a substrate in solid form. The company's high pressure systems can accept speciality alloy powders and manufacture large high-spec components.

The broker was pleased to see that the ASX stock has signed a contract with a leading US defence prime contractor. It said:

TTT has announced an Early Manufacturing Development (EMD) contract with a leading US defence prime contractor, valued at US$1.7m and expected to be completed by mid-2026. TTT will manufacture "next generation" defence sector components at its Huntsville Alabama facility. The contract leverages TTT's propriety Titomic Kinetic Fusion cold spray additive manufacturing capabilities.

The broker feels that while it is early days, the successful delivery of this contract could bring about further contracts. It explains:

While it is a relatively early stage proof of concept agreement, successful delivery could lead to qualification and low-rate initial production contracts. The "next generation" designation for "defence modernization initiatives" implies a high-end technology application. TTT has previously outlined defence markets to include hypersonic systems, satellites, munitions and launchers as key segments of the addressable market; hypersonics and satellites being the most advanced applications.

Big potential returns

According to the note, Bell Potter has retained its speculative buy rating and 50 cents price target on the ASX defence stock.

Based on its current share price of 23 cents, this implies potential upside of almost 120% for investors over the next 12 months.

Commenting on its speculative buy recommendation, Bell Potter concludes:

TTT provides leverage to the emerging application of its cold spray technology in AM for defence, aerospace and natural resources markets. US defence spending as a percentage of GDP is at a cyclical low and is expected to lift over the coming decade. NATO members have recently announced increased spending commitments. We expect news flow relating to TTT's participation in US defence programs, new commercial agreements and non-dilutive government-backed funding. We have made no changes to our earnings outlook or valuation in this report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A happy man looks at his smart phone, indicating a share price rise for ASX tech shares
Technology Shares

Codan shares hit another all-time high. Can the rally keep going?

The next test will come in February when the company releases its results.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Technology Shares

Buy this ASX tech stock now for the long run

Brokers see 60%+ upside for this sports tech share.

Read more »

A silhouette of a soldier flying a drone at sunset.
Technology Shares

Aussie defence stocks tick higher on bullish Trump comments

A massive increase in defence spending has been flagged.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Technology Shares

Is the WiseTech Global share price about to shock us all in 2026?

After a difficult year marked by uncertainty and execution risk, WiseTech enters 2026 with a clearer strategy and lower expectations.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Technology Shares

Guess which ASX 200 stock is rocketing 24% on impressive half year profit update

This growing company had another strong half. Here's what it expects to report next month.

Read more »

Doctor checking patient's spine x-ray image.
Technology Shares

This ASX technology company's shares are surging more than 20% on a new contract win

A new contract win has this company's management "excited".

Read more »

Man controlling a drone in the sky.
Technology Shares

This ASX tech stock is in focus after fresh US news

Elsight shares are in focus after the company secured a new US order, highlighting growing commercial adoption of its drone…

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »